Lifestyle

LOTTE SHOPPING CO., LTD. Purchases Gimhae Outlet Site from Hotel Lotte for 63.5 Billion Won

Jamsil Site to Be Leased for 16.9 Billion Won

KYUNG GYEYOUNG
2026-11-13 16:31:14
[Edaily Reporter KYUNG GYEYOUNG ] Lotte Shopping ( LOTTE SHOPPING CO., LTD.(023530)) announced on the 13th that it has agreed to purchase a land stake in Sinmun-dong, Gimhae, South Gyeongsang Province, from its affiliate, Lotte Hotel, for 63.5 billion won.

This site is home to the Lotte Premium Outlet Gimhae. LOTTE SHOPPING CO., LTD. previously owned a portion of the site and will now secure the entire property through this purchase.

LOTTE SHOPPING CO., LTD. explained that this acquisition was made to enhance financial and operational efficiency.

In addition, LOTTE SHOPPING CO., LTD. announced on the same day that it would lease a plot of land in Jamsil-dong, Songpa-gu, Seoul, from Lotte Hotel for 16.9 billion won. The lease term runs from January 1, 2026, to December 31, 2028.

The company stated that this lease covers the portion of the land used in excess of LOTTE SHOPPING CO., LTD.’s ownership stake.

(Photo: LOTTE SHOPPING CO., LTD.)

Economy

Corporation

IT·Science

Economy

[Exclusive] HANWHA SOLUTIONS Transfers ‘Hanwha Simaron’ to Hanwha Defense… Expects Financial Improvement and Synergies

HANWHA SOLUTIONS(009830)It has been confirmed that Hanwha Solutions has sold its U.S.-based high-pressure tank manufacturing subsidiary, “Hanwha Cimarron LLC,” to Hanwha Defense USA, the U.S. defense …
2026-11-13 15:37:03

Corporation

Burdened by Raw Material Costs and Voluntary Retirement Expenses… Pulmuone Corporate’s Third-Quarter Operating Profit Down 89.6%

Pulmuone Corporate’s operating profit for the third quarter of this year fell to one-tenth of the level recorded in the same period last year. Although sales increased, profitability in its domestic b…
2026-11-13 16:40:27

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02